Laparoscopic hiatal herniorrhaphy has become the standard practice for most surgeons to perform anti-reflux surgery. The purpose of this study was to investigate the therapeutic effect of laparoscopic esophageal hiatal herniorrhaphy.

a total of 25 patients with esophageal hiatal hernia diagnosed in our hospital from 2017 to 2019 were treated with laparoscopic esophageal hiatal herniorrhaphy, including 7 cases of gastric fundus partial folding (Toupet) and 18 cases of gastric fundus folding (Nissen). All patients completed gastroesophageal reflux disease questionnaire (Gerd Q) before and after operation, and the differences of Gerd Q and extraesophageal symptoms before and after operation were statistically analyzed.

all the 25 cases of laparoscopic esophageal hiatal hernia repair were successful. The operation time was 110 (70~190) min, blood loss 10~50 h mL; after operation 24 h~48 h fluid diet. There were no complications such as incision infection, postoperative massive hemorrhage, patch adverse reactions and so on. All patients were hospitalized for an average of 7~11 days and followed up for an average of 8.6 months. The health-related symptoms such as chest pain, acid regurgitation, belching and asthma were significantly improved in most patients. There was significant difference in Gerd Q score between pre-operation and post-operation.

laparoscopic esophageal hiatal herniorrhaphy is a feasible method with satisfactory results, it has the advantages of faster recovery, less trauma and less postoperative complications, so it is worth further popularizing and applying in clinic.